Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$10M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 37 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 8,400 | $87.15 | $732.1K | -1.5% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,500 | $86.36 | $215.9K | -0.4% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 16 | $97.46 | $1.6K | 0.0% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 1,392 | $96.82 | $134.8K | -0.2% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,635 | $95.93 | $540.6K | -1.0% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 7,157 | $95.10 | $680.6K | -1.2% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 800 | $93.97 | $75.2K | -0.1% | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 590 | $88.91 | $52.5K | -0.1% | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 4,234 | $88.12 | $373.1K | -0.7% | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 10,176 | $87.44 | $889.8K | -1.7% | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 3,294 | $71.38 | $235.1K | -0.5% | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 8,149 | $70.50 | $574.5K | -1.3% | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 3,557 | $69.40 | $246.9K | -0.6% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 300 | $74.96 | $22.5K | <0.1% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 1,700 | $74.23 | $126.2K | -0.3% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 3,100 | $73.14 | $226.7K | -0.5% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 1,000 | $71.76 | $71.8K | -0.2% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 3,600 | $70.77 | $254.8K | -0.6% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,300 | $69.54 | $368.6K | -0.8% | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,656 | $49.92 | $132.6K | -0.4% | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 12,344 | $49.20 | $607.3K | -1.9% | Open the original filing on SEC.gov |
| Mar 23 | DMRA | Damora Therapeutics, Inc. | AGRANT◆ | 37,313 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 9,100 | $42.49 | $386.7K | -1.4% | Open the original filing on SEC.gov |
| Mar 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,900 | $41.73 | $246.2K | -0.9% | Open the original filing on SEC.gov |
| Feb 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 14,043 | $32.87 | $461.6K | -2.1% | Open the original filing on SEC.gov |
| Feb 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 957 | $31.82 | $30.5K | -0.1% | Open the original filing on SEC.gov |
| Jan 9 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 528,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 100 | $32.39 | $3.2K | <0.1% | Open the original filing on SEC.gov |
| Jan 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,191 | $31.79 | $69.7K | -0.3% | Open the original filing on SEC.gov |
| Jan 2 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 12,709 | $30.47 | $387.2K | -1.8% | Open the original filing on SEC.gov |
| Dec 1, 2025 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 4,005 | $29.83 | $119.5K | -0.6% | Open the original filing on SEC.gov |
| Dec 1, 2025 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 10,995 | $28.73 | $315.9K | -1.6% | Open the original filing on SEC.gov |
| Nov 3, 2025 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 16,845 | $23.66 | $398.6K | -2.3% | Open the original filing on SEC.gov |
| Nov 3, 2025 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 28,155 | $23.13 | $651.2K | -3.8% | Open the original filing on SEC.gov |
| Jun 2, 2025 | ORKA | Oruka Therapeutics, Inc. | AGRANT◆ | 17,500 | — | — | — | Open the original filing on SEC.gov |